Latest News about RGNX

Recent news which mentions RGNX

< Previous 1 2 3 4 5 Next >

Earnings Preview For Regenxbio

November 07, 2023

12 Health Care Stocks Moving In Monday's After-Market Session

October 30, 2023

Stocks That Hit 52-Week Lows On Thursday

October 05, 2023

What 4 Analyst Ratings Have To Say About Regenxbio

October 04, 2023

Stocks That Hit 52-Week Lows On Monday

September 11, 2023

The Latest Analyst Ratings for Regenxbio

August 29, 2023

Earnings Preview: Regenxbio

August 01, 2023

What 6 Analyst Ratings Have To Say About Regenxbio

July 12, 2023

5 Analysts Have This to Say About Regenxbio

June 20, 2023

RegenXbio's Potential Blockbuster: Analyst is Bullish On Stock Citing Potential Gains From AAV Gene Therapies Resurgence

June 20, 2023

Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023

June 20, 2023

The Latest Analyst Ratings for Regenxbio

June 02, 2023

Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2023

June 02, 2023

Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

May 16, 2023

Regenxbio's Return On Capital Employed Insights

May 11, 2023

Analyst Expectations for Regenxbio's Future

May 09, 2023

Does an FDA Fast Track Designation Make Regenxbio Stock a Buy Now?

April 15, 2023

Tesla To Rally Over 16%? Here Are 10 Other Analyst Forecasts For Monday

March 06, 2023

3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday

March 01, 2023

Earnings Scheduled For February 28, 2023

February 28, 2023

Earnings Preview: Regenxbio

February 27, 2023

Looking Into Regenxbio's Return On Capital Employed

November 22, 2022

5 Analysts Have This to Say About Regenxbio

November 21, 2022

What 5 Analyst Ratings Have To Say About Regenxbio

November 04, 2022

Regenxbio Says Diabetic Retinopathy Gene Therapy Shows Meaningful Improvements In Disease Severity

November 03, 2022

Recap: Regenxbio Q3 Earnings

November 03, 2022

Earnings Scheduled For November 3, 2022

November 03, 2022

Regenxbio's Earnings Outlook

November 02, 2022

Despite Solid Efficacy From Gene Therapy, This Analyst Cuts REGENXBIO's Price Target

October 04, 2022

Alphabet To $114? Plus This Analyst Predicts $145 For Disney

October 04, 2022

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.